https://www.leo-pharma.it/2026-03-11T15:36:53+00:00https://www.leo-pharma.it/chi-siamo2024-03-24T16:58:14+00:00https://www.leo-pharma.it/aree-terapeutiche2024-03-18T14:07:32+00:00https://www.leo-pharma.it/ricerca-e-sviluppo2024-03-09T13:24:59+00:00https://www.leo-pharma.it/responsabilita-sociale2026-03-25T11:11:23+00:00https://www.leo-pharma.it/lavora-con-noi2024-03-18T17:12:22+00:00https://www.leo-pharma.it/news2026-03-11T15:41:29+00:00https://www.leo-pharma.it/contatti2024-04-15T10:11:46+00:00https://www.leo-pharma.it/privacy-e-note-legali2024-04-15T11:09:30+00:00https://www.leo-pharma.it/chi-siamo/mission-e-valori2024-03-18T13:23:08+00:00https://www.leo-pharma.it/chi-siamo/leo-pharma-italia2024-10-15T13:13:53+00:00https://www.leo-pharma.it/chi-siamo/la-nostra-storia2024-04-08T18:28:04+00:00https://www.leo-pharma.it/chi-siamo/leo-foundation2024-03-26T15:50:56+00:00https://www.leo-pharma.it/aree-terapeutiche/dermatologia2025-02-24T20:19:47+00:00https://www.leo-pharma.it/aree-terapeutiche/trombosi2024-03-26T15:51:56+00:00https://www.leo-pharma.it/aree-terapeutiche/dermatologia/dermatite-atopica2024-03-24T17:01:37+00:00https://www.leo-pharma.it/aree-terapeutiche/dermatologia/psoriasi2024-03-25T14:35:57+00:00https://www.leo-pharma.it/aree-terapeutiche/dermatologia/altre-patologie2024-03-18T14:33:45+00:00https://www.leo-pharma.it/aree-terapeutiche/dermatologia/eczema-cronico-delle-mani2025-02-25T12:28:53+00:00https://www.leo-pharma.it/ricerca-e-sviluppo/r,-a-,d2024-03-09T13:17:50+00:00https://www.leo-pharma.it/ricerca-e-sviluppo/ecosistema-dell%E2%80%99innovazione2024-03-09T13:20:53+00:00https://www.leo-pharma.it/ricerca-e-sviluppo/dall%E2%80%99idea-al-farmaco2024-03-18T15:14:26+00:00https://www.leo-pharma.it/ricerca-e-sviluppo/la-pipeline2024-03-18T15:26:57+00:00https://www.leo-pharma.it/responsabilita-sociale/diversita-equita-e-inclusione2025-11-11T15:20:24+00:00https://www.leo-pharma.it/responsabilita-sociale/strategia-csr2024-03-21T09:28:57+00:00https://www.leo-pharma.it/responsabilita-sociale/associazioni-di-pazienti2026-02-11T15:17:43+00:00https://www.leo-pharma.it/responsabilita-sociale/hcp-e-organizzazioni-sanitarie2025-06-24T09:37:37+00:00https://www.leo-pharma.it/responsabilita-sociale/codice-di-condotta2025-05-19T20:53:48+00:00https://www.leo-pharma.it/responsabilita-sociale/modello-dlgs-231,-s-,012024-04-03T08:43:54+00:00https://www.leo-pharma.it/responsabilita-sociale/governance2026-03-25T11:11:02+00:00https://www.leo-pharma.it/lavora-con-noi/lavorare-in-leo-pharma2024-03-18T16:14:20+00:00https://www.leo-pharma.it/lavora-con-noi/aree-professionali2024-03-19T11:00:13+00:00https://www.leo-pharma.it/lavora-con-noi/posizioni-aperte2024-03-18T16:49:31+00:00https://www.leo-pharma.it/lavora-con-noi/aree-professionali/leo-pharma-italia2024-03-18T16:45:29+00:00https://www.leo-pharma.it/news/dermatite-atopica-disponibile-in-italia-il-trattamento-con-anticorpo-monoclonale-tralokinumab2024-09-18T13:41:43+00:00https://www.leo-pharma.it/news/la-commissione-europea-approva-delgocitinib-di-leo-pharma-per-il-trattamento-degli-adulti2024-10-01T19:20:42+00:00https://www.leo-pharma.it/news/leo-pharma-consegna-a-domicilio-del-farmaco-biologico-per-i-pazienti-con-psoriasi2024-09-18T12:49:15+00:00https://www.leo-pharma.it/news/leo-pharma-finalizza-lacquisizione-dei-key-asset-di-timber-pharmaceuticals2024-09-18T12:57:57+00:00https://www.leo-pharma.it/news/leo-pharma-italia-ha-ottenuto-la-certificazione-per-la-parita-di-genere2025-02-25T16:39:08+00:00https://www.leo-pharma.it/news/prendi-in-mano-la-tua-vita-la-nuova-campagna-leo-pharma-di-sensibilizzazione2026-02-11T15:16:07+00:00https://www.leo-pharma.it/news/al-virtual-congress-eadv-2021-leo-pharma-presenta2024-04-18T08:28:21+00:00https://www.leo-pharma.it/news/con-una-crescita-del-7-nel-2019-laumento-dei-margini-e-il-successo-della-pipeline2024-04-18T08:29:14+00:00https://www.leo-pharma.it/news/dermatologicamente-progetto-di-supporto-psicologico-a-distanza2024-04-18T08:29:33+00:00https://www.leo-pharma.it/news/eadv-2020-presentati-i-dati-di-tralokinumab-relativi-alla-sicurezza2024-04-18T08:30:17+00:00https://www.leo-pharma.it/news/i-risultati-positivi-di-uno-studio-di-fase-2b-per-defi2024-04-18T08:30:35+00:00https://www.leo-pharma.it/news/leo-pharma-acquisisce-i-diritti-per-lo-sviluppo-e-la-commercial2024-04-03T11:30:14+00:00https://www.leo-pharma.it/news/leo-pharma-annuncia-l-approvazione-da-parte-della-commissione-europea-di-tralokinumab2024-04-03T11:30:01+00:00https://www.leo-pharma.it/news/leo-pharma-avvia-il-primo-trial-clinico-di-fase-3-con-delgocitinib2024-04-03T11:30:23+00:00https://www.leo-pharma.it/news/leo-pharma-avvia-studio-head-to-head-per-la-valutazione-di-brodalumab-vs2024-04-03T11:30:20+00:00https://www.leo-pharma.it/news/leo-pharma-conclusa-acquisizione-dei-farmaci-dermatologici-di-bayer-soggetti-a-prescrizione-e2024-04-03T11:29:57+00:00https://www.leo-pharma.it/news/leo-pharma-consegna-a-domicilio-del-farmaco-biologico-per-i-pazienti2024-04-03T11:29:55+00:00https://www.leo-pharma.it/news/leo-pharma-e-morphosys-estendono-la-loro-alleanza-strategica2024-04-03T11:30:16+00:00https://www.leo-pharma.it/news/leo-pharma-e-portal-instruments-annunciano-una-collaborazione-per-lo-sviluppo-di-un2024-04-03T11:30:25+00:00https://www.leo-pharma.it/news/leo-pharma-inaugura-il-sito-produttivo-di-segrate2024-04-03T11:30:22+00:00https://www.leo-pharma.it/news/leo-pharma-riceve-il-parere-positivo-del-chmp-su-tralokinumab-per-il-trattamento2024-04-03T11:30:03+00:00https://www.leo-pharma.it/news/leo-pharma-sottoscritto-accordo-di-licenza-per-il-farmaco-fb8252024-04-03T11:29:54+00:00https://www.leo-pharma.it/news/leo-pharma-spa-entra-a-far-parte-di-farmindustria2024-04-03T11:30:25+00:00https://www.leo-pharma.it/news/nuovi-dati-dimostrano-che-brodalumab-di-leo-pharma-garantisce-maggiori-probabilita2024-04-03T11:30:05+00:00https://www.leo-pharma.it/news/psoriasi-moderata-grave-disponibile-in-italia-brodalumab-una-pelle-libera-da-lesioni2024-04-03T11:29:52+00:00https://www.leo-pharma.it/news/segrate-leo-pharma-manufacturing-italy-dona-un-velobus-alla-citta2024-04-18T08:32:27+00:00https://www.leo-pharma.it/news/tinzaparina-sodica-disponibile-in-italia-per-prevenire-e-curare-il-tromboembolismo-venoso2024-04-18T08:31:17+00:00